C11orf55 Activators
C11orf55 can initiate a cascade of intracellular events that result in the protein's activation through various signaling pathways. Forskolin, by directly stimulating adenylyl cyclase, increases the levels of cAMP within cells, which in turn activates protein kinase A (PKA). PKA, a pivotal kinase in cellular signaling, can phosphorylate C11orf55 if it is among its substrates, leading to its activation. Similarly, Isoproterenol, a beta-adrenergic agonist, also raises cAMP levels, albeit through the stimulation of beta-adrenergic receptors, with the same potential outcome on C11orf55 via PKA. The cAMP analog, Dibutyryl-cAMP (db-cAMP), bypasses cell surface receptors and directly activates PKA, offering another route to potentially activate C11orf55 through phosphorylation. In the realm of calcium-dependent modulation, Ionomycin acts as a calcium ionophore that elevates intracellular calcium levels. This elevation can activate proteins like calmodulin-dependent kinases, which may then interact with and activate C11orf55 if it is part of the calcium signaling network.
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which phosphorylates numerous proteins. If C11orf55 is a PKC substrate or is regulated by PKC-mediated phosphorylation, PMA can lead to its activation. Epidermal Growth Factor (EGF) and Insulin, through their respective receptors, initiate signaling cascades like PI3K/Akt and MAPK/ERK, which could include C11orf55 activation if it is involved in these pathways. Anisomycin, a potent activator of MAPK pathways, particularly JNK and p38, could also phosphorylate and activate C11orf55 if it is within the MAPK signaling network. Okadaic Acid prevents the dephosphorylation of proteins by inhibiting protein phosphatases, which could result in an increase in the phosphorylated and active state of C11orf55. Finally, S-Nitroso-N-acetylpenicillamine (SNAP) increases cGMP levels through the release of nitric oxide, which activates cGMP-dependent protein kinases that may target C11orf55 for activation. Zinc Pyrithione and Hydrogen Peroxide both modulate redox signaling, which can lead to the activation of C11orf55 if it is sensitive to redox changes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which phosphorylates a variety of protein targets. If C11orf55 is regulated by PKC or is a substrate of PKC, activation of PKC by PMA would lead to the activation of C11orf55 through phosphorylation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. If C11orf55 is regulated by calcium signaling or associated proteins that respond to calcium (such as calmodulin-dependent kinases), the increase in intracellular calcium could lead to the activation of C11orf55. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels in cells through activation of beta-adrenergic receptors. The subsequent activation of PKA could lead to the phosphorylation and activation of C11orf55 if it is part of the PKA signaling cascade. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor, leading to the activation of the PI3K/Akt signaling pathway. If C11orf55 is downstream of Akt or is regulated by Akt-mediated phosphorylation, insulin could lead to the activation of C11orf55. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates MAPK pathways, particularly JNK and p38. If C11orf55 is regulated by MAPK pathway members or is a substrate for MAPK-induced phosphorylation, anisomycin treatment could result in the activation of C11orf55. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is an inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), leading to increased phosphorylation levels of proteins. If C11orf55 is normally dephosphorylated by PP1 or PP2A, inhibition by okadaic acid could result in the activation of C11orf55 due to reduced dephosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog. It activates PKA, and if C11orf55 is a PKA substrate or is regulated by proteins that are PKA substrates, db-cAMP could lead to the activation of C11orf55 through phosphorylation events. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc Pyrithione can increase intracellular reactive oxygen species (ROS) and alter redox signaling. If C11orf55 activity is sensitive to redox changes or is regulated by proteins that respond to ROS, Zinc Pyrithione could enhance the activation of C11orf55 through oxidative modifications. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen Peroxide is a ROS that can modulate signaling pathways through oxidative stress. If C11orf55 contains redox-sensitive domains or interacts with redox-sensitive proteins, the increase in ROS from Hydrogen Peroxide could lead to the activation of C11orf55. | ||||||